Trials / Sponsors / D3 Bio (Wuxi) Co., Ltd
D3 Bio (Wuxi) Co., Ltd
Industry · 5 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Phase 1 Study of D3S-003 as Monotherapy in Participants With Advanced Solid Tumors With a KRAS p.G12D Mutati KRAS P.G12D | Phase 1 | 2026-03-31 |
| Completed | A Phase 1 Study to Assess Food Effect on the Pharmacokinetics of D3S-001 in Healthy Adult Participants Healthy Adult Volunteers | Phase 1 | 2025-07-11 |
| Recruiting | A Study of D3L-001 as Monotherapy in Subjects With HER2-Positive Advanced Solid Tumors HER-2 Positive Advanced Solid Tumors | Phase 1 | 2023-09-19 |
| Active Not Recruiting | A Phase 1/2 Study of D3S-002 as Monotherapy or Combination Therapy in Adult Subjects With Advanced Solid Tumor Advanced Solid Tumors With MAPK Pathway Mutations | Phase 1 / Phase 2 | 2023-07-10 |
| Recruiting | A Study of D3S-001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.G12 KRAS P.G12C | Phase 1 / Phase 2 | 2022-08-03 |